| Bioactivity | Defensin HNP-1 human TFA is a Human neutrophil peptides (HNPs), involved in endothelial cell dysfunction at the time of early atherosclerotic development. Defensin HNP-1 human TFA exhibits broad antimicrobial and anti-leishmanial activities[1][2]. | ||||||
| Name | Defensin HNP-1 human TFA | ||||||
| Shortening | ACYCRIPACIAGERRYGTCIYQGRLWAFCC | ||||||
| Formula | C152H229F3N44O40S6 | ||||||
| Molar Mass | 3556.05 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Defensin HNP-1 human TFA
CAS: F: C152H229F3N44O40S6 W: 3556.05
Defensin HNP-1 human TFA is a Human neutrophil peptides (HNPs), involved in endothelial cell dysfunction at the time of
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.